CytoNiche Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $47.2M

  • Investors
  • 16

CytoNiche General Information

Description

Developer of 3D micro-structure engineering technology used for stem cell research. The company specializes in the research of 3D cell tissue engineering for the development of high-quality stem cell cultures, injectable 3D micro-tissue treatment and 3D drug screening microcarrier used for extensive drug screening operations, providing reliable 3D micro-tissue products and services for research institutes, clinical institutions, stem cell companies and drug research enterprises.

Contact Information

Website
www.cytoniche.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 208, Building 1, Zone B
  • Yiyuan Wenchuang Base, Haidian District
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 208, Building 1, Zone B
  • Yiyuan Wenchuang Base, Haidian District
  • Beijing
  • China
+86 010

CytoNiche Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoNiche Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 03-Mar-2022 $47.2M Completed Generating Revenue
3. Early Stage VC (Series A1) 28-Apr-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Sep-2020 Completed Generating Revenue
1. Seed Round 01-Mar-2019 Completed Startup
To view CytoNiche’s complete valuation and funding history, request access »

CytoNiche Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 10

    Pending

  • Expiring in next 12 mo

CytoNiche Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4151305-A1 Preparation method for microcarrier applicable in three-dimensional cell culturing and reaction apparatus Pending 12-May-2020
US-20230077045-A1 Method for preparing microcarrier suitable for three-dimensional cell culture and reaction apparatus Pending 12-May-2020
EP-4151305-A4 Preparation method for microcarrier applicable in three-dimensional cell culturing and reaction apparatus Pending 12-May-2020
US-20220162560-A1 Three-dimensional culture method for large-scale preparation of stem cells Pending 31-Jan-2019
EP-3933032-A1 Three-dimensional culture method for large-scale preparation of stem cells Pending 31-Jan-2019 C12N5/0667
To view CytoNiche’s complete patent history, request access »

CytoNiche Executive Team (3)

Name Title Board Seat
Wei Liu Ph.D Co-Founder and Chief Executive Officer
Yan Xiaojun Ph.D Co-Founder & Chief Technology Officer
Du Yanan Ph.D Chief Scientific Officer
To view CytoNiche’s complete executive team members history, request access »

CytoNiche Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
CICC Capital PE/Buyout Minority
Gaorong Capital Venture Capital Minority
Hongtai Capital Holdings Venture Capital Minority
Sinopharm Capital Venture Capital Minority
Sinovac Corporation Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

CytoNiche FAQs

  • When was CytoNiche founded?

    CytoNiche was founded in 2018.

  • Who is the founder of CytoNiche?

    Wei Liu Ph.D and Yan Xiaojun Ph.D are the founders of CytoNiche.

  • Who is the CEO of CytoNiche?

    Wei Liu Ph.D is the CEO of CytoNiche.

  • Where is CytoNiche headquartered?

    CytoNiche is headquartered in Beijing, China.

  • What industry is CytoNiche in?

    CytoNiche’s primary industry is Drug Discovery.

  • Is CytoNiche a private or public company?

    CytoNiche is a Private company.

  • What is CytoNiche’s current revenue?

    The current revenue for CytoNiche is .

  • How much funding has CytoNiche raised over time?

    CytoNiche has raised $47.2M.

  • Who are CytoNiche’s investors?

    CICC Capital, Gaorong Capital, Hongtai Capital Holdings, Sinopharm Capital, and Sinovac are 5 of 16 investors who have invested in CytoNiche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »